Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Sebastiani

Showing results (61-70 of 209) with videos related to

Pageof 21
Sort By:
HIV Medicine|August 30, 2022
Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infectionDana Kablawi, Alshaima Alhinai, Philip Wong, et al.
Plos One|January 11, 2014
Iron-dependent regulation of hepcidin in Hjv-/- mice: evidence that hemojuvelin is dispensable for sensing body iron levelsKonstantinos Gkouvatsos, Carine Fillebeen, Alina Daba, et al.
CMAJ Open|December 5, 2019
The hepatitis C virus cascade of care in a Quebec provincial prison: a retrospective cohort studyNadine Kronfli, Camille Dussault, Marina B Klein, et al.
Inflammatory Bowel Diseases|July 6, 2016
Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel DiseaseTalat Bessissow, Ngoc Han Le, Kathleen Rollet, et al.
Open Forum Infectious Diseases|June 3, 2015
Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunodeficiency virus mono-infected patientsGiada Sebastiani, Kathleen C Rollet-Kurhajec, Costa Pexos, et al.
World Journal of Gastroenterology|December 14, 2020
Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndromeMohamed Shengir, Srinivasan Krishnamurthy, Peter Ghali, et al.
World Journal of Gastroenterology|September 29, 2016
Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review articleChe-Yung Chao, Robert Battat, Alex Al Khoury, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2020
Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver DiseaseYuly Mendoza, Sila Cocciolillo, Giuseppe Murgia, et al.
Journal of Hepatology|December 17, 2009
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis CLaurent Castéra, Giada Sebastiani, Brigitte Le Bail, et al.
Diabetes Care|January 8, 2025
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 DiabetesRicheek Pradhan, Hui Yin, Sally Lu, et al.
Pageof 21

Showing results (61-70 of 209) with videos related to

Sort By:
Pageof 21
HIV Medicine|August 30, 2022
Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infectionDana Kablawi, Alshaima Alhinai, Philip Wong, et al.
Plos One|January 11, 2014
Iron-dependent regulation of hepcidin in Hjv-/- mice: evidence that hemojuvelin is dispensable for sensing body iron levelsKonstantinos Gkouvatsos, Carine Fillebeen, Alina Daba, et al.
CMAJ Open|December 5, 2019
The hepatitis C virus cascade of care in a Quebec provincial prison: a retrospective cohort studyNadine Kronfli, Camille Dussault, Marina B Klein, et al.
Inflammatory Bowel Diseases|July 6, 2016
Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel DiseaseTalat Bessissow, Ngoc Han Le, Kathleen Rollet, et al.
Open Forum Infectious Diseases|June 3, 2015
Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunodeficiency virus mono-infected patientsGiada Sebastiani, Kathleen C Rollet-Kurhajec, Costa Pexos, et al.
World Journal of Gastroenterology|December 14, 2020
Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndromeMohamed Shengir, Srinivasan Krishnamurthy, Peter Ghali, et al.
World Journal of Gastroenterology|September 29, 2016
Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review articleChe-Yung Chao, Robert Battat, Alex Al Khoury, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2020
Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver DiseaseYuly Mendoza, Sila Cocciolillo, Giuseppe Murgia, et al.
Journal of Hepatology|December 17, 2009
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis CLaurent Castéra, Giada Sebastiani, Brigitte Le Bail, et al.
Diabetes Care|January 8, 2025
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 DiabetesRicheek Pradhan, Hui Yin, Sally Lu, et al.
Pageof 21